Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - REVENUE
Revenue ALLO - Allogene Therapeutics, Inc.
95 K
LAST VALUE
-95.03%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR